108 related articles for article (PubMed ID: 11768617)
1. Keyhole limpet hemocyanin (KLH) conjugate vaccines as novel therapeutic tools in malignant disorders.
Schumacher K
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R1-2. PubMed ID: 11768617
[No Abstract] [Full Text] [Related]
2. Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience.
Musselli C; Livingston PO; Ragupathi G
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R20-6. PubMed ID: 11768620
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
Ragupathi G; Cappello S; Yi SS; Canter D; Spassova M; Bornmann WG; Danishefsky SJ; Livingston PO
Vaccine; 2002 Jan; 20(7-8):1030-8. PubMed ID: 11803062
[TBL] [Abstract][Full Text] [Related]
4. Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine.
Neelapu SS; Baskar S; Kwak LW
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R14-9. PubMed ID: 11768619
[TBL] [Abstract][Full Text] [Related]
5. Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.
Kafi K; Betting DJ; Yamada RE; Bacica M; Steward KK; Timmerman JM
Mol Immunol; 2009 Jan; 46(3):448-56. PubMed ID: 19046770
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.
Kantele A; Häkkinen MP; Zivny J; Elson CO; Mestecky J; Kantele JM
Clin Dev Immunol; 2011; 2011():614383. PubMed ID: 21716728
[TBL] [Abstract][Full Text] [Related]
7. Conjugates of aberrant gangliosides in antiglioma vaccine: toxicological assay.
Lombardi V; Shnaar R; Minev B; Misasi R; Gitstsi Kh; Sorice M; Troncone A
Bull Exp Biol Med; 2002 Oct; 134(4):363-5. PubMed ID: 12533760
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of the ID-KLH vaccination with local GM-CSF in patients with follicular lymphomas (published in Nature Med 1999; 5: 1171-1177) summary of the lecture by L. W. Kwak.
Schumacher K
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R10-3. PubMed ID: 11768618
[No Abstract] [Full Text] [Related]
9. Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.
Timmerman JM; Levy R
J Immunol; 2000 May; 164(9):4797-803. PubMed ID: 10779787
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.
Kim SK; Ragupathi G; Musselli C; Choi SJ; Park YS; Livingston PO
Vaccine; 1999 Nov; 18(7-8):597-603. PubMed ID: 10547417
[TBL] [Abstract][Full Text] [Related]
11. Marine tumor vaccine carriers: structure of the molluscan hemocyanins KLH and htH.
Markl J; Lieb B; Gebauer W; Altenhein B; Meissner U; Harris JR
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R3-9. PubMed ID: 11768622
[TBL] [Abstract][Full Text] [Related]
12. A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.
Kosten TA; Shen XY; O'Malley PW; Kinsey BM; Lykissa ED; Orson FM; Kosten TR
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():223-9. PubMed ID: 23739535
[TBL] [Abstract][Full Text] [Related]
13. Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma.
Tusé D; Ku N; Bendandi M; Becerra C; Collins R; Langford N; Sancho SI; López-Díaz de Cerio A; Pastor F; Kandzia R; Thieme F; Jarczowski F; Krause D; Ma JK; Pandya S; Klimyuk V; Gleba Y; Butler-Ransohoff JE
Biomed Res Int; 2015; 2015():648143. PubMed ID: 26425548
[TBL] [Abstract][Full Text] [Related]
14. [Hemocyanins as immunostimulants].
Del Campo M; Arancibia S; Nova E; Salazar F; González A; Moltedo B; De Ioannes P; Ferreira J; Manubens A; Becker MI
Rev Med Chil; 2011 Feb; 139(2):236-46. PubMed ID: 21773663
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.
Pan Y; Chefalo P; Nagy N; Harding C; Guo Z
J Med Chem; 2005 Feb; 48(3):875-83. PubMed ID: 15689172
[TBL] [Abstract][Full Text] [Related]
16. Effects of parenteral keyhole limpet hemocyanin or cholera toxin on intestinal immune response to keyhole limpet hemocyanin.
Hamilton SR; Keren DF; Yardley JH; Brown G
Int Arch Allergy Appl Immunol; 1982; 68(3):242-6. PubMed ID: 7085119
[TBL] [Abstract][Full Text] [Related]
17. A conjugate of an oligosaccharide fragment of tumor-associated ganglioside antigen with hemocyanin is a prototype antitumor vaccine.
Stepanenko RN; Tsvetkov YE; Khatuntseva EA; L'vov VL; Vlasenko RY; Nifant'ev NE; Petrov RV
Dokl Biol Sci; 2007; 415():298-301. PubMed ID: 17929671
[No Abstract] [Full Text] [Related]
18. On the emerging role of chemistry in the fashioning of biologics: synthesis of a bidomainal fucosyl GM1-based vaccine for the treatment of small cell lung cancer.
Nagorny P; Kim WH; Wan Q; Lee D; Danishefsky SJ
J Org Chem; 2009 Aug; 74(15):5157-62. PubMed ID: 19555091
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
Dickler MN; Ragupathi G; Liu NX; Musselli C; Martino DJ; Miller VA; Kris MG; Brezicka FT; Livingston PO; Grant SC
Clin Cancer Res; 1999 Oct; 5(10):2773-9. PubMed ID: 10537341
[TBL] [Abstract][Full Text] [Related]
20. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
